Fast and Furious: Melanoma Research in 2015
By Louise M. Perkins, Ph.D., MRA Chief Science Officer | 28 December 2015 In Science, Treatment
The world of melanoma has changed dramatically in a way one might not have envisioned in 2011. How can you tell? From the stories of patients and their caregivers. A common story can go like this: Just diagnosed with Stage 4 melanoma.
Daughter Celebrates Her Mom's Health This Holiday Season
In this guest post, Hilary Rogers, a member of the Leveraged Finance Fights Melanoma Steering Committee, shares her perspective on her mom's battle with melanoma. In the winter of 2012, my family and I found out that our mother’s stage 3 melanoma diagnosis had progressed to her lungs.
Is a Clinical Trial Right for You?
Before the U.S. Food and Drug Administration (FDA) approves a medication or treatment for public use, it first must go through several phases of study which is known as a clinical trial. During each phase, researchers evaluate how well the treatment works and take note of any side effects.
By Logan Kastner, MRA Director of Marketing and Development | 24 November 2015 In Allies & Partnerships
Partnering for Cures: How Patients Can Stop Talking and Start Doing Something
Earlier this week, more than 700 thought leaders from throughout the healthcare industry gathered in New York for FasterCures’ Partnering for Cures meeting. This annual event brings together a variety of decision-makers from across diseases who are motivated by the same mission – to reduce the time and cost of...
Immunotherapy Patient Forum: 6 Reasons to Attend
27 October 2015 In Events
On November 7, the Melanoma Research Alliance is co-hosting a Patient Forum on Immunology with Global Resource for Advancing Cancer Education and the Society for Immunotherapy of Cancer. The event will be held at the National Harbor, near Washington, DC. Online registration is open through October 30.
A Father Shares His Family's Journey with Melanoma
In this guest blog post, Skip Grinberg shares his family's experience with melanoma and his drive to advance research. [caption id="attachment_1505" align="alignright" width="300"] Skip Grinberg and his extended family[/caption] Life can occasionally throw you a sharp-breaking curveball.
Melanoma and the Problem of Drug Resistance
8 October 2015 In Science
In 2002, researchers discovered a link between mutated BRAF genes and nearly half of all melanoma tumors. Since then, BRAF inhibitors—drugs that target mutated BRAF—have become a leading go-to weapon in the battle against melanoma. Their job is to cut off signals sent by altered BRAF that promote the rapid...
Adjuvant Therapy Advocacy ASCO Awareness Board Members BRAF Cancer Combination Therapy Detection FDA Grants Immunotherapy Melanoma microbiome MRA Partners Patient Forum Patient Stories Patient-Centric Care Patients Pediatric Melanoma Prevention Research Science Social Media Targeted Therapy Teens Treatment Wendy Selig Young Investigators Young People